China Orthopedic Instrument Industry Report, 2013-2015
  • Sep./2013
  • Hard Copy
  • USD $2,100
  • Pages:93
  • Single User License
    (PDF Unprintable)       
  • USD $2,000
  • Code: LT006
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,100
  • Hard Copy + Single User License
  • USD $2,300
      
Benefiting from aging of population, consumption upgrade and policy support, China's orthopedic instrument industry has seen rapid development over the years, with total market size rising from 3.28 billion yuan in 2006 to 9.85 billion yuan in 2012.

Trauma products, spine products and joint products constitute the three major market segments of Chinese orthopedic instrument industry. In 2012, the three principal products accounted for an aggregate market share of about 82.2%, of which, trauma products showed the highest, approximately 35.5%, with market size up 18.24% YoY; spine and joint products ranked second (up 12.6% YoY) and third (up 12.4% YoY), respectively.

Market Share of Major Orthopedic Trauma Instrument Enterprises in China, 2012
?20130240.png

In recent years, along with the increasing investment of foreign-funded enterprises in China, the trend of foreign monopoly has been more evident. After the acquisition of Synthes in 2012, Johnson & Johnson has turned into the largest company in China's orthopedic instrument market, with market share of both trauma and spine products occupying the first place.

In November 2012, Medtronic purchased KangHui Medical for $816 million, thus making an important step in Chinese orthopedic instrument market localization. Compared with Medtronic's high-end positioning, affordable KangHui products can help Medtronic expand low- and medium-end markets in emerging countries and regions (including China). In 2012, Medtronic (including KangHui Medical) occupied 15.9% of China's spine market.

Stryker is a world-renowned orthopedic instrument enterprise, and its joint products account for about 20% of global market share. In January 2013, Stryker acquired Trauson Holdings for $764 million, and in virtue of the latter’s R&D and manufacturing capacity and distribution network advantages further expanded its market share in China, expected to occupy 8%-10% of China's orthopedic market in 2013.

Relying on powerful R&D strength and mature distribution network, Weigao has already become the largest local supplier of orthopedic devices in China. In 2012, its orthopedic device business achieved revenue of 223 million yuan, and trauma equipment products occupied market share of 5.1% or so.

In future, the Chinese orthopedic instrument market will encounter more fierce competition, in which small companies due to low R&D level, insufficient production capacity and non-standard quality control tend to be gradually eliminated, and the market will be further concentrated in industry magnates with superb financial and technical strength.

China Orthopedic Instrument Industry Report, 2013-2015 of ResearchInChina mainly covers the followings:

20120114.gif?Overview, market structure and development prospect, etc. of global orthopedic instrument industry;
20120114.gif? Market structure, competition pattern, barriers to entry, import & export, etc. of China orthopedic instrument industry;
20120114.gif? Development environment (including policy environment, development prospects as well as development of upstream and downstream industries) for China orthopedic instrument industry;
20120114.gif? Operating conditions, etc. of 12 orthopedic instrument companies (including Johnson & Johnson, Medtronic, Stryker, Weigao, Shanghai Kinetic, Beijing AKEC Medical, United Orthopedic Corporation, etc.) in China.
1. Overview of Orthopedic Instrument Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain

2. Development of Global Orthopedic Instrument Industry
2.1 Overview
2.2 Development Prospect 

3. Development of China Orthopedic Instrument Industry
3.1 Overview
3.2 Market Structure
3.3 Import & Export
3.3.1 Import
3.3.2 Export
3.4 Competition Pattern
3.5 Barriers to Entry
3.5.1 Technology
3.5.2 Market Access
3.5.3 Sales Channel
3.5.4 Talent
3.6 Sales Model

4. Development Environment for China Orthopedic Instrument Industry
4.1 Policy Environment
4.1.1 Regulatory Policy
4.1.2 Industry Policy
4.2 Upstream and Downstream Industries
4.2.1 Upstream
4.2.2 Downstream
4.3 Development Prospects

5. Key Companies in China
5.1 Johnson & Johnson
5.1.1 Profile
5.1.2 Operation 
5.1.3 Orthopedic Instrument Business
5.1.4 Business in China
5.2 Medtronic
5.2.1 Profile
5.2.2 Operation
5.2.3 Orthopedic Instrument Business
5.2.4 Revenue Structure
5.2.5 Business in China
5.3 Stryker
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Business in China
5.4 Weigao
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Orthopedic Instrument Business
5.4.5 Gross Margin
5.4.6 R&D and Investment
5.4.7 Clients
5.4.8 Forecast and Outlook
5.5 Shanghai Kinetic Medical Co., Ltd. (KMC)
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Orthopedic Instrument Business
5.5.5 Gross Margin
5.5.6 R&D and Investment
5.5.7 Clients and Suppliers
5.5.8 Forecast and Outlook
5.6 United Orthopedic Corporation
5.6.1 Profile
5.6.2 Operation
5.6.3 Revenue Structure
5.6.4 Orthopedic Instrument Business
5.6.5 Gross Margin
5.6.6 R&D and Investment
5.6.7 Clients and Suppliers
5.7 Beijing AKEC Medical Co. Ltd. (AKEC)
5.7.1 Profile
5.7.2 Operation
5.7.3 Revenue Structure 
5.7.4 Gross Margin
5.7.5 R&D and Investment
5.7.6 Clients and Suppliers
5.8 Suzhou Xinrong Best Medical Instrument Co,. Ltd.
5.8.1 Profile
5.8.2 Operation
5.9 Tianjin Walkman Biomaterial Co., Ltd.
5.9.1 Profile 
5.9.2 Operation
5.10 Beijing Montagne Medical Device Co., Ltd.
5.10.1 Profile
5.10.2 Operation
5.11 Beijing Lidakang Science and Technology Co., Ltd.
5.11.1 Profile
5.11.2 Operation
5.12 Renli Orthopedics Medical Instrument Limited Company
5.12.1 Profile
5.12.2 Operation
Orthopedic Instrument Industry Category
Orthopedic Instrument Industry Chain
Global Medical Device Industry Market Size, 2007-2016
Global Orthopedic Instrument Market Size and Growth Rate, 2002-2012
Global Orthopedic Instrument Market Share (by Product), 2012
Global Orthopedic Instrument Market Size (by Region), 2015
Global Orthopedic Instrument Market Size (by Product), 2015
China’s Orthopedic Instrument Industry Market Size and Growth Rate, 2006-2012
China’s Orthopedic Instrument Market Size (by Product), 2007-2012
China’s Import Volume and Value of Orthopedic or Fracture Appliances, 2006 – Jan.-Jul. 2013
Top 10 Countries (Regions) by China’s Import Volume of Orthopedic or Fracture Appliances, 2012
China’s Import Volume and Value of Artificial Joints, 2007 – Jan.-Jul. 2013
China’s Export Volume and Value of Orthopedic or Fracture Appliances, 2007 – Jan.-Jul. 2013
Top 10 Countries (Regions) by China’s Export Volume of Orthopedic or Fracture Appliances, 2012
China’s Export Volume and Value of Artificial Joints, 2007 – Jan.-Jul. 2013
Market Share of Major Orthopedic Trauma Instrument Enterprises in China, 2012
Market Share of Major Spine Orthopedic Instrument Enterprises in China, 2012
Orthopedic Instrument Product Approval Application Process
China’s Orthopedic Instrument Sales Process
Main Content of Orthopedic Instrument Industry Policies in China, 2007-2012
China's Total Health Care Expenditure As a Percentage of GDP, 2000-2012
Population Aged 65 and Above (% of Total) in China, 1982-2012
China’s Per Capita Disposable Income of Urban Residents and Per Capita Net Income of Rural Households, 2001-2012
Chinese Health Insurance Coverage and Spending Levels, 2012
Health Insurance Coverage Limits for Orthopedic Implants in Some Provinces and Cities of China, 2011
China’s Orthopedic Instrument Industry Market Size, 2008-2014
China’s Car Ownership, 2007-2012
China’s Orthopedic Instrument Industry Market Size (by Product), 2011-2014
Revenue and Net Income of Johnson & Johnson, 2008-2012
Revenue Structure of Johnson & Johnson, (by Product), 2012
Johnson & Johnson’s Revenue from Orthopedic Business and % of Total Revenue, 2010-2012
Major Products of Johnson & Johnson’s Companies in China
Revenue and Total Profit of Johnson & Johnson Medical (Suzhou), 2008-2009
Gross Margin of Johnson & Johnson Medical (Suzhou), 2008-2009
Total Assets and Total Liabilities of Johnson & Johnson Medical (Suzhou), 2008-2009
Revenue and Net Income of Medtronic, FY2008-FY2013
Gross Margin of Medtronic, FY2009-FY2013
Medtronic’s Revenue from Spine Products and % of Total Revenue, FY2008-FY2013
Revenue Structure of Medtronic (by Product), FY2011-FY2013
Revenue Structure of Medtronic (by Region), FY2009-FY2013
Revenue and Net Income of KangHui Medical, 2008-2011
Revenue Structure of KangHui Medical (by Product), 2008-2011
Revenue Structure of KangHui Medical (by Region), 2008-2011
Gross Margin of KangHui Medical, 2008-2011
R&D Costs and % of Total Revenue of KangHui Medical, 2008-2011
Revenue and Net Income of Stryker, 2008-2012
Stryker’s Revenue from Orthopedic Instrument Business and % of Total Revenue, 2010-2012
Revenue Structure of Stryker (by Product), 2009-2012
Revenue Structure of Stryker (by Region), 2009-2012
Output of Major Products of Trauson Holdings, 2008-2011
Capacity Utilization of Major Products of Trauson Holdings, 2008-2011
Revenue and Net Income of Trauson Holdings, 2008-2012
Revenue Structure of Trauson Holdings (by Product), 2008-2012
Revenue Structure of Trauson Holdings (by Region), 2008-2012
Number of Agents and Authorized Hospitals of Trauson Holdings, 2009-2012
Revenue Structure of Trauson (China) Medical Instrument and Changzhou Orthmed Medical Instrument (by Region), 2008-2011
Gross Margin of Trauson Holdings, 2008-2012
R&D Costs and % of Total Revenue of Trauson Holdings, 2008-2012
Product Categories and Major Products of Weigao
Revenue and Net Income of Weigao, 2008-2013
Sales and Distribution Network of Weigao, 2012
Revenue Structure of Weigao (by Product), 2009-2013
Output Growth of Weigao’s Conventional Medical Supplies (by Product), 2009-2012
Revenue Structure of Weigao’s Conventional Medical Supplies, 2006-2012
Major High Value-added Products of Weigao’s Conventional Medical Supplies
Revenue Breakdown of Weigao (by Region), 2008-2012 
Orthopedic Instrument Production of Weigao, 2008-2012
Orthopedic Instrument Revenue and Growth of Weigao, 2008-2013
Gross Margin and Net Profit Margin of Weigao, 2004-2012
R&D Costs and % of Total Revenue of Weigao, 2008-2012
Weigao’s Patents and Registration Certificates, 2007-2012
Client Bases of Weigao, 2007-2012
Hospital Customers of Weigao (by Grade), 2012
Average Sales per Customer and Growth of Weigao, 2008-2012
Revenue and Net Income of Weigao, 2012-2015
Revenue and Net Income of KMC, 2008-2013
Revenue Structure of KMC (by Product), 2008-2013
Revenue Structure of KMC (by Region), 2009-2012
Cost and Effect Comparison: PKP/PVP Surgery System vs. Conventional Treatment
PKP and PVP Surgery System Sales Volume of KMC, 2009-2012
Comparison of Vertebroplasty Product Consumption: China vs. United States 
Provinces with PKP Covered by Medical Insurance in China
Gross Margin of KMC, 2008-2013
Gross Margin Breakdown of KMC (by Product), 2008-2011
R&D Costs and % of Total Revenue of KMC, 2010-2012
KMC’s Reserve R&D Projects
KMC’s Patents, 2010-2012
KMC’s Revenue from Top 5 Clients and % of Total Revenue, 2009-2012
Main Raw Material Purchases of KMC, 2009-2011
Revenue and Net Income of KMC, 2012-2015
Revenue and Net Income of United Orthopedic Corporation, 2008-2012
Revenue Structure of United Orthopedic Corporation (by Region), 2008-2012
Revenue Structure of United Orthopedic Corporation (by Product), 2011-2012
Capacity, Output and Output Value of Artificial Joints of United Orthopedic Corporation, 2010-2011
Gross Margin of United Orthopedic Corporation, 2008-2012
R&D Costs and % of Total Revenue of United Orthopedic Corporation, 2009-2012
United Orthopedic Corporation’s Procurement from Top 3 Suppliers and % of Total Procurement, 2010-2012
United Orthopedic Corporation’s Revenue from Top 3 Clients and % of Total Revenue, 2010-2012
Capacity, Output and Capacity Utilization of AKEC, 2009-2011
Vaccine Output, Sales Volume and Sales-output Ratio of AKEC, 2009-2011
Revenue and Net Income of AKEC, 2009-2011
Revenue Structure of AKEC (by Product), 2008-2011
Revenue Structure of AKEC (by Region), 2008-2011
Gross Margin of AKEC, 2009-2011
Gross Margin of Major Products of AKEC, 2009-2011
R&D Costs and % of Total Revenue of AKEC, 2009-2011
AKEC’s Planned/Ongoing Projects and Investment, 2012
Name List and Revenue Contribution of AKEC’s Top 5 Clients, 2009-2011
AKEC’s Procurement from Top 5 Suppliers and % of Total Procurement, 2009-2012
Revenue and Total Profit of Suzhou Xinrong Best Medical Instrument, 2007-2009
Gross Margin of Suzhou Xinrong Best Medical Instrument, 2007-2009
Total Assets and Total Liabilities of Suzhou Xinrong Best Medical Instrument, 2007-2009
Revenue and Total Profit of Tianjin Walkman Biomaterial, 2007-2009
Gross Margin of Tianjin Walkman Biomaterial, 2007-2009
Total Assets and Total Liabilities of Tianjin Walkman Biomaterial, 2007-2009
Revenue and Total Profit of Beijing Montagne Medical Device, 2007-2009
Gross Margin of Beijing Montagne Medical Device, 2007-2009
Total Assets and Total Liabilities of Beijing Montagne Medical Device, 2007-2009
Revenue and Total Profit of Beijing Lidakang Science and Technology, 2007-2009
Gross Margin of Beijing Lidakang Science and Technology, 2007-2009
Total Assets and Total Liabilities of Beijing Lidakang Science and Technology, 2007-2009
Revenue and Total Profit of Renli Orthopedics, 2007-2009
Gross Margin of Renli Orthopedics, 2007-2009
Total Assets and Total Liabilities of Renli Orthopedics, 2007-2009

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统